HS Code Subheading

Medicaments; containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale

3004.60 Subheading
Section VI — Products of the chemical or allied industries

About HS Code 300460

This HS code is dedicated to medicaments containing antimalarial active principles, as defined by Subheading Note 2 to Chapter 30, packaged for retail sale and used for therapeutic or prophylactic purposes. The trade in these drugs is critically important for global health, particularly in malaria-endemic regions. International aid organizations, governments, and non-governmental organizations are major importers, facilitating access to life-saving treatments. Exporters are typically pharmaceutical companies with the capacity to produce these specialized drugs, often under stringent quality control. Challenges include combating drug resistance, ensuring affordability, and managing complex supply chains to reach remote areas. Research and development for new antimalarial compounds also drives a portion of this specialized pharmaceutical trade.

Products Under This Code

Artemether-lumefantrine tablets, Chloroquine phosphate tablets, Doxycycline capsules (for malaria prophylaxis), Mefloquine tablets, Primaquine tablets, Atovaquone-proguanil tablets, Quinine bisulfate capsules

Real World Examples

Coartem (artemether/lumefantrine), Malarone (atovaquone/proguanil), Lariam (mefloquine), Aralen (chloroquine), Doxy-PEP (doxycycline)

Common Misclassification

Can be confused with 300490 (other medicaments) if the specific antimalarial active principles are not clearly identified, or 2939 for bulk antimalarial compounds.

Products Classified Under 3004.60

Industry

This code belongs to the Chemicals industry.

Trade Overview

Sub-Saharan African countries and Southeast Asian nations are primary importers, while pharmaceutical companies in India, China, and Europe are key exporters.

Frequently Asked Questions

What is HS code 300460?

HS code 300460 covers: Medicaments; containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale. This HS code is dedicated to medicaments containing antimalarial active principles, as defined by Subheading Note 2 to Chapter 30, packaged for retail sale and used for therapeutic or prophylactic purposes. The trade in these drugs is critically important for global health, particularly in malaria-endemic regions. International aid organizations, governments, and non-governmental organizations are major importers, facilitating access to life-saving treatments. Exporters are typically pharmaceutical companies with the capacity to produce these specialized drugs, often under stringent quality control. Challenges include combating drug resistance, ensuring affordability, and managing complex supply chains to reach remote areas. Research and development for new antimalarial compounds also drives a portion of this specialized pharmaceutical trade.

What products fall under HS code 300460?

Artemether-lumefantrine tablets, Chloroquine phosphate tablets, Doxycycline capsules (for malaria prophylaxis), Mefloquine tablets, Primaquine tablets, Atovaquone-proguanil tablets, Quinine bisulfate capsules

What are common misclassifications for HS code 300460?

Can be confused with 300490 (other medicaments) if the specific antimalarial active principles are not clearly identified, or 2939 for bulk antimalarial compounds.

How is HS code 300460 structured?

HS code 300460 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (04) identify the heading, and digits 5-6 (60) specify the subheading. This code is standardized globally by the World Customs Organization.